Cargando…
The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography
BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) are widely used for the management of prostate cancer (PCa). However, how these modalities complement each other in PCa risk stratification is still largely unknown. We aim to provide insights into...
Autores principales: | Nilsson, Erik, Sandgren, Kristina, Grefve, Josefine, Jonsson, Joakim, Axelsson, Jan, Lindberg, Angsana Keeratijarut, Söderkvist, Karin, Karlsson, Camilla Thellenberg, Widmark, Anders, Blomqvist, Lennart, Strandberg, Sara, Riklund, Katrine, Bergh, Anders, Nyholm, Tufve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636013/ https://www.ncbi.nlm.nih.gov/pubmed/37945817 http://dx.doi.org/10.1038/s43856-023-00394-7 |
Ejemplares similares
-
Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [(68)Ga]PSMA-11-PET and [(11)C]Acetate-PET
por: Sandgren, Kristina, et al.
Publicado: (2023) -
Registration of histopathology to magnetic resonance imaging of prostate cancer
por: Sandgren, Kristina, et al.
Publicado: (2021) -
Radiation dosimetry of [(68)Ga]PSMA-11 in low-risk prostate cancer patients
por: Sandgren, Kristina, et al.
Publicado: (2019) -
Impact of neoadjuvant androgen deprivation therapy on magnetic resonance imaging features in prostate cancer before radiotherapy
por: Björeland, Ulrika, et al.
Publicado: (2021) -
Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study
por: Björeland, Ulrika, et al.
Publicado: (2023)